Form 4: Repare Therapeutics Director Samarth Kulkarni Acquires Stock Options

Director Samarth Kulkarni of Repare Therapeutics Inc. [RPTX] acquired stock options on June 17, 2024.

Summary

• Samarth Kulkarni, a director of Repare Therapeutics Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on June 17, 2024.
• Kulkarni acquired stock options (right to buy) for 27,200 common shares at an exercise price of $3.80.
• The options vest in equal monthly installments over twelve months from the grant date, contingent upon continued service.
• Following the transaction, Kulkarni directly owns 27,200 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock option grants, which is neutral in sentiment.

Future Outlook

The stock options vest monthly over a 12-month period, incentivizing continued service from the director.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, such as directors and officers, trade in their company's securities. This provides transparency to the market.

Stakeholder Impact

• The acquisition of stock options by a director aligns their interests with those of the shareholders, potentially incentivizing them to work towards increasing shareholder value.

Key Dates